{"title":"Comparison of US elastography and chemical shift magnetic resonance imaging in multifidus muscle fatty degeneration.","authors":"Fatıh Kırcın, Bahar Yanık, Erdogan Bulbul, Emrah Akay, Gulen Demırpolat","doi":"10.24875/CIRU.24000048","DOIUrl":"https://doi.org/10.24875/CIRU.24000048","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this study was to investigate the feasibility of the use of shear wave elastography (SWE) in comparison to chemical shift encoding (CSE) magnetic resonance imaging (MRI) for the evaluation of multifidus muscle fatty degeneration in patients with chronic low back pain.</p><p><strong>Method: </strong>Multifidus muscles were evaluated with the CSE-MRI and SWE examinations in control and patient groups. With the in-phase and out-phase sequences in CSE-MRI, signal intensity index (SII), and signal intensity suppression ratio (SISR) values; with the SWE method, shear wave velocity values were determined. Differences in the mean values of these parameters per level and study group were analyzed by Student's t-test.</p><p><strong>Results: </strong>SWE revealed significantly lower stiffness at the L2-3 level, consistent with the signal index values (SII-SISR) showing increased fatty infiltration on MRI in the patient group. No such relationship was found at the L4-5 level or in control group.</p><p><strong>Conclusions: </strong>SWE may be a promising method to show muscle fatty infiltration at L2-3 level in patients with chronic low back pain.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 5","pages":"633-640"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ivette Mata-Maqueda, Juan C Solís-Sáinz, Guadalupe Zaldivar-Lelo de Larrea, Ernesto Deloya-Tomas, Jorge López-Fermín, Mª Guadalupe Olvera-Ramos, Gabriela Castillo-Gutiérrez, Jorge D Carrión-Moya, Orlando R Pérez-Nieto
{"title":"Acute kidney injury and mortality in patients with critical COVID-19 in Mexico: case-control study.","authors":"Ivette Mata-Maqueda, Juan C Solís-Sáinz, Guadalupe Zaldivar-Lelo de Larrea, Ernesto Deloya-Tomas, Jorge López-Fermín, Mª Guadalupe Olvera-Ramos, Gabriela Castillo-Gutiérrez, Jorge D Carrión-Moya, Orlando R Pérez-Nieto","doi":"10.24875/CIRU.23000207","DOIUrl":"https://doi.org/10.24875/CIRU.23000207","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to test the association between acute kidney injury (AKI) and mortality in critically ill patients with Coronavirus disease 2019 (COVID-19).</p><p><strong>Method: </strong>We conducted a single-center case-control study at the intensive care unit (ICU) of a second-level hospital in Mexico. We included 100 patients with critical COVID-19 from January to December 2021, and collected demographic characteristics, comorbidities, APACHE II, SOFA, NEWS2, and CO-RADS scores at admission, incidence of intrahospital complications, length of hospital and ICU stay, and duration of mechanical ventilation, among others.</p><p><strong>Results: </strong>The median survival of deceased patients was 20 days. After multivariable logistic regression, the following variables were significantly associated to mortality: AKI (adjusted odds ratio [AOR] 6.64, 95% confidence intervals [CI] = 2.1-20.6, p = 0.001), age > 55 years (AOR 5.3, 95% CI = 1.5-18.1, p = 0.007), and arrhythmias (AOR 5.15, 95% CI = 1.3-19.2, p = 0.015). Median survival was shorter in patients with AKI (15 vs. 22 days, p = 0.043), as well as in patients with overweight/obesity (15 vs. 25 days, p = 0.026).</p><p><strong>Conclusion: </strong>Our findings show that the development of AKI was the main risk factor associated with mortality in critical COVID-19 patients, while other factors such as older age and cardiac arrhythmias were also associated with this outcome. The management of patients with COVID-19 should include renal function screening and staging on admission to the Emergency Department.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 5","pages":"626-632"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142483165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emily S Valadez-Méndez, Sol Ramírez-Ochoa, Leonardo Perales-Guerrero, Shaúl A Navarro-Lara, Liliana B Alcázar-García, Carlos J Moreno-Bernardino, Javier Solís-Estrada, Silvia G Esquivel-Razo, Miguel A Buenrostro-Ahued, Enrique Cervantes-Pérez
{"title":"Nutritional care of the patient after metabolic surgery: a misunderstood discipline.","authors":"Emily S Valadez-Méndez, Sol Ramírez-Ochoa, Leonardo Perales-Guerrero, Shaúl A Navarro-Lara, Liliana B Alcázar-García, Carlos J Moreno-Bernardino, Javier Solís-Estrada, Silvia G Esquivel-Razo, Miguel A Buenrostro-Ahued, Enrique Cervantes-Pérez","doi":"10.24875/CIRU.22000515","DOIUrl":"https://doi.org/10.24875/CIRU.22000515","url":null,"abstract":"","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 6","pages":"839-840"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The effect of antiangiogenic agent aflibercept on surgically induced endometriosis in a rat model.","authors":"Caglayan Ates, Berna Dilbaz, Seval Yılmaz Ergani, Fuad Atabay","doi":"10.24875/CIRU.23000072","DOIUrl":"10.24875/CIRU.23000072","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the study is to show for the first time how aflibercept affects endometriosis lesions.</p><p><strong>Material and methods: </strong>Surgically induced endometriosis in Wistar albino female rats. Rats with endometriosis were randomly divided into three groups: control (Co), aflibercept (Af), and leuprolide acetate (Le). Then, Af, aflibercept, and Le received leuprolide acetate. The control group was not treated. The weights and changes in intra-abdominal adhesions of the rats before and after treatment were recorded according to the Blauer adhesion score. Blood extracted for sacrifice was analyzed. Endometriotic lesions were evaluated for size, volume, histology, and immunohistochemistry (vascular endothelial growth factor [VEGF] and CD31). Significance level was accepted as p < 0.05.</p><p><strong>Results: </strong>Aflibercept significantly reduced endometrial implant volume (p = 0.002). The explant epithelial histological score showed a significant difference between aflibercept and leuprolide acetate (p = 0.006) and between aflibercept and control groups (p = 0.002). Aflibercept decreased VEGF-H and CD31 expression (p = 0.001) more than leuprolide acetate. Aflibercept improved adhesions (p = 0.006).</p><p><strong>Conclusion: </strong>Aflibercept is more successful than leuprolide acetate in the treatment of endometriosis.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 1","pages":"10-19"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Garcia, Antonia Pastore, Javier Rodriguez, Fernando Crovari, Jaime Cerda, Patricia Rebolledo, Pablo Achurra, Eduardo Viñuela, Jorge Martinez, Martin Dib, Eduardo Briceño
{"title":"Risk factors for readmission after a cholecystectomy: a case-control study.","authors":"Daniel Garcia, Antonia Pastore, Javier Rodriguez, Fernando Crovari, Jaime Cerda, Patricia Rebolledo, Pablo Achurra, Eduardo Viñuela, Jorge Martinez, Martin Dib, Eduardo Briceño","doi":"10.24875/CIRU.23000057","DOIUrl":"10.24875/CIRU.23000057","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to assess the risk factors associated with 30-day hospital readmissions after a cholecystectomy.</p><p><strong>Methods: </strong>We conducted a case-control study, with data obtained from UC-Christus from Santiago, Chile. All patients who underwent a cholecystectomy between January 2015 and December 2019 were included in the study. We identified all patients readmitted after a cholecystectomy and compared them with a randomized control group. Univariate and multivariate analyses were conducted to identify risk factors.</p><p><strong>Results: </strong>Of the 4866 cholecystectomies performed between 2015 and 2019, 79 patients presented 30-day hospital readmission after the surgical procedure (1.6%). We identified as risk factors for readmission in the univariate analysis the presence of a solid tumor at the moment of cholecystectomy (OR = 7.58), high pre-operative direct bilirubin (OR = 2.52), high pre-operative alkaline phosphatase (OR = 3.25), emergency admission (OR = 2.04), choledocholithiasis on admission (OR = 4.34), additional surgical procedure during the cholecystectomy (OR = 4.12), and post-operative complications. In the multivariate analysis, the performance of an additional surgical procedure during cholecystectomy was statistically significant (OR = 4.24).</p><p><strong>Conclusion: </strong>Performing an additional surgical procedure during cholecystectomy was identified as a risk factor associated with 30-day hospital readmission.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 1","pages":"3-9"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparing complex decongestive therapy in patients with lymphedema of different causes by measuring: extremity volume, quality of life, and functionality.","authors":"Cansu Sahbaz-Pirincci, Emine Cihan, Ülkü Düzlü-Öztürk, Pınar Borman, Meltem Dalyan","doi":"10.24875/CIRU.23000330","DOIUrl":"https://doi.org/10.24875/CIRU.23000330","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the effects of complex decongestive therapy (CDT) applied to the lower extremities of patients with lymphedema of different causes on the extremity volume, quality of life (QoL), and functionality.</p><p><strong>Materials and method: </strong>The study included 90 patients, of whom 28 had primary lymphedema, 30 had secondary lymphedema, 18 had phlebolymphedema, and 14 had lipolymphedema. A total of 137 extremities were treated with CDT. The patients who received CDT for 5 days a week for 3 weeks (15 sessions in total) were included in the sample. Extremity volume was measured using a tape measure. The lymphedema QoL-Leg Questionnaire was used to evaluate QoL, and the lower extremity functional scale (LEFS) was administered to assess lower extremity functionality.</p><p><strong>Results: </strong>The changes in QoL before and after treatment significantly differed in the primary lymphedema, phlebolymphedema, and lipolymphedema groups (p < 0.05). The post-treatment LEFS scores indicated a significant decrease in the phlebolymphedema and lipolymphedema groups compared to the pre-treatment scores (p < 0.05).</p><p><strong>Conclusions: </strong>The difference in appearance, which is one of the sub-parameters of QoL, significantly decreased in the comparisons performed between the groups, whereas the changes in the remaining parameters were not significant.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 3","pages":"354-361"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"SynDaver<sup>®</sup> synthetic human cadaver: a 3D simulator for anatomy education and surgical training.","authors":"Manuel Uribe-Miranda","doi":"10.24875/CIRU.22000369","DOIUrl":"https://doi.org/10.24875/CIRU.22000369","url":null,"abstract":"","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 3","pages":"417-418"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Zidovudine, a brief history before the first antirretroviral in Mexico.","authors":"Hans Malagón-Tejeida","doi":"10.24875/CIRU.22000250","DOIUrl":"https://doi.org/10.24875/CIRU.22000250","url":null,"abstract":"<p><p>In the 1980s in Mexico, that of the «moral renewal», there was the opening to the market and the manifestation of human immunodeficiency virus (HIV) and AIDS. In this writing, the historical and therapeutic conditions are related to alleviate the syndrome until the arrival of the first antiretroviral. It is a reconstruction of the events, of which the medical-social, main clinical manifestations and of course the pharmacological therapy, until de the development zidovudina or azidotimidina of AZT, the first antiretroviral to be approved. Nevertheless, in the Mexican context, this event wasn't decisive to significantly change the morbility and the mortality.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 3","pages":"408-414"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Óscar V Hernández-Mondragón, Luis F García-Contreras
{"title":"Endoscopic submucosal dissection for the treatment of gastrointestinal neoplasia in a tertiary-care center in Mexico.","authors":"Óscar V Hernández-Mondragón, Luis F García-Contreras","doi":"10.24875/CIRU.23000052","DOIUrl":"https://doi.org/10.24875/CIRU.23000052","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to evaluate the experience of using endoscopic submucosal dissection (ESD), a technique considered as first-line of treatment, for the management of early neoplastic lesions (ENL), and subepithelial lesions (SEL) < 4 cms in size, in a tertiary-care, high-volume medical center in Mexico.</p><p><strong>Method: </strong>Patients > 18 years-old, candidates to ESD with ENL and SMT, between January 2008 and October 2022 were included.</p><p><strong>Results: </strong>ESD was performed in 246 patients (137 ENL and 109 SMT), 52.2% gastric, 23.1% colonic, 19.5% esophageal and 5.2% in duodenum. Benign/premalignant were 74.4%, and 25.6% malignant, being the SMT the most frequent (44.3%) and gastrointestinal stromal tumor. En-bloc resection, R0, and curative resection rates were 97.2%, 94.5%, and 85.8%, respectively. The most common adverse event was transprocedural bleeding (18.3%) followed by perforation (6.9%), both endoscopically treated without mortality. Recurrence was presented in 9.44% at 177 months of follow-up.</p><p><strong>Conclusions: </strong>ESD is a safe and effective endoscopic surgical option of treatment for ENL and SMT in Mexican population when performed in experienced centers.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 6","pages":"776-787"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arlette R Ordóñez-Flores, José J Rivera-Sánchez, M Valeria Jiménez-Baez, David Rojano-Mejía, Macedonia G Moreno-Tovar, Alma I Guerrero-Martínez
{"title":"Comparing costs and timing of ankle sprain care in two first-tier care systems.","authors":"Arlette R Ordóñez-Flores, José J Rivera-Sánchez, M Valeria Jiménez-Baez, David Rojano-Mejía, Macedonia G Moreno-Tovar, Alma I Guerrero-Martínez","doi":"10.24875/CIRU.23000024","DOIUrl":"10.24875/CIRU.23000024","url":null,"abstract":"<p><strong>Objective: </strong>To compare the costs of care and the opportunity of care for the management of grade I-II ankle sprain in two Family Medicine Units, one with rehabilitation service (FMU 13) and one without rehabilitation service (FMU 41).</p><p><strong>Method: </strong>Observational analytical study, records with diagnosis of grade I-II ankle sprain attended at the FMU were included January-November 2021. Consultations were recorded in the emergency department, family medicine, rehabilitation, cabinet studies and time to grant the appointment in the rehabilitation service (opportunity of care), the Mann-Whitney U test was used to compare costs of care and timeliness of care.</p><p><strong>Results: </strong>In FMU 41, care costs were higher compared to FMU 13 ($13,990 vs $8,063); however, this difference was not significant, as was the cost of care in family medicine, rehabilitation, and opportunity of care.</p><p><strong>Conclusions: </strong>The costs of care and the opportunity of care were similar in both models of care (FMU 13-FMU 41) of grade I-II ankle sprain.</p>","PeriodicalId":93936,"journal":{"name":"Cirugia y cirujanos","volume":"92 6","pages":"751-757"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142735234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}